BONGIOVANNI, Alberto
 Distribuzione geografica
Continente #
EU - Europa 127.990
NA - Nord America 614
AS - Asia 88
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 1
Totale 128.699
Nazione #
IE - Irlanda 127.595
US - Stati Uniti d'America 614
FI - Finlandia 97
IT - Italia 95
UA - Ucraina 79
CN - Cina 77
DE - Germania 39
GB - Regno Unito 23
BE - Belgio 18
RO - Romania 17
SE - Svezia 10
RU - Federazione Russa 9
EU - Europa 6
IN - India 6
FR - Francia 3
NL - Olanda 2
AT - Austria 1
CH - Svizzera 1
CL - Cile 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
TR - Turchia 1
Totale 128.699
Città #
Dublin 127.595
Ann Arbor 88
Ashburn 72
Chandler 46
Jacksonville 44
Fairfield 43
Des Moines 42
Woodbridge 34
Houston 28
Wilmington 28
Palermo 25
Brussels 18
Medford 16
Seattle 16
Cambridge 15
Nanjing 14
Princeton 12
Boardman 9
Shenyang 9
Tulsa 9
New York 8
Altamura 7
Jinan 7
Nanchang 7
Beijing 6
Changsha 6
Washington 6
Zhengzhou 6
Dearborn 5
Kumar 5
Lawrence 5
Ludwigshafen am Rhein 4
Rome 4
San Mateo 4
Verona 4
Falls Church 3
Hebei 3
Jiaxing 3
Norwalk 3
Tianjin 3
Auburn Hills 2
Changzhou 2
Helsinki 2
Lanzhou 2
Milan 2
San Diego 2
Durham 1
Guangzhou 1
Haikou 1
Hangzhou 1
Hanover 1
Izmir 1
Kilburn 1
Lecce 1
Levanto 1
Moscow 1
Nanning 1
Ningbo 1
Orange 1
San Paolo di Civitate 1
Santiago 1
Seongnam 1
Shaoxing 1
Stuttgart 1
Taiyuan 1
Taizhou 1
Tehran 1
Terni 1
Totale 128.296
Nome #
Analisi della frequenza del polimorfismo 1249-1250insACAA del gene TGF-beta2 in un gruppo di pazienti affette da carcinoma della mammella. 127.702
“Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma” 168
“Cytokine gene polymorphisms and breast cancer susceptibility” 153
Prognostic value of vascular endothelial growth factor (VEGF) and D-Dimer (DD) levels in cancer patients 109
“Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with metastatic (M) breast cancer (BC): results of an observational study” 94
“Serum HER-2/neu (s-HER2) levels evaluation in breast cancer (BC) patients (PTS)” 92
Weekly docetaxel (wDOC) for the treatment of metastatic breast cancer (MBC): A literature based meta-analysis 90
“Analysis of serum HER-2/neu levels (S-HER2) in breast cancer (BC) patients (pts)” 86
"Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with early (E) breast cancer (BC)” 78
“Final results of a phase II trial of a weekly (W) poly-chemotherapy (CT) with cisplatin (CDDP), epirubicin (EPI), fluorouracil (5FU), folinic acid (FA) and G-CSF for the treatment of gastroesophageal (GE) and gastric (G) cancer (C)” 71
“Results of a phase II study of a weekly regimen of cisplatin (CDDP),epirubicin (EPI), fluorouracil (5FU) and folinic acid (FA) with G-CSF in gastroesophageal (GE) and gastric (G) cancer” 64
Totale 128.707
Categoria #
all - tutte 130.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201917 0 0 0 0 0 0 0 0 0 0 8 9
2019/2020237 25 2 14 10 23 28 25 15 27 14 35 19
2020/2021144 2 18 3 17 16 1 14 8 25 11 14 15
2021/2022113 5 26 2 2 5 9 5 3 19 12 2 23
2022/2023201 35 20 3 15 20 29 37 12 16 0 6 8
2023/2024111 14 9 3 17 15 17 10 23 1 1 1 0
Totale 128.707